Out-licensing
Up-to-date access to technology licensing opportunities worldwide.
- Out-licensing
- Browse
Licensing opportunities
The present technology describes recombinant poxvirus vectors encoding at least three or more costimulatory molecules and tumor associated antigens (TAAs). More
Low Concentration Hypochlorous Acid Producing Technology More
Related Reports
Market Research Reports provided by reports.iptechex.com
Dec 2010 - 37 pages - $500
Nov 2010 - 40 pages - $500
May 2011 - 15 pages - $250
Jan 2011 - 34 pages - $500
Nov 2010 - 933 pages - $1,495
Nov 2010 - 308 pages - $1,495
Nov 2010 - 330 pages - $1,495
Nov 2010 - 527 pages - $1,495
Nov 2011 - 7 pages - $3,835
Jan 2010 - $75
Your selection
Browse By
- Industry sector
- Animal health
- Biotechnology
- Diagnostic
- Drug delivery
- Drug discovery
- Medical device
- Pharmaceutical
- Research tools
- Therapeutic target
- Adoptive immunotherapy
- Amyloidosis
- Autoimmune disease (non-specific)
- Chronic fatigue syndrome
- Chronic granulomatous disease
- Chronic immunosuppression
- Gout
- Graft versus host disease
- HIV/AIDS
- Immune disorder (non-specific)
- Immune thrombocytopenic purpura
- Immunomodulation
- Immunostimulation
- Immunosuppression
- Lupus erythematosis
- Myalgic encephalomyelitis
- Myasthenia gravis
- Neoplastic disease
- Organ transplant rejection
- Rheumatoid arthritis
- Servere combined immunodeficency
- Sjogren's syndrome
- Systemic sclerosis
- Transplant rejection
- Xenotransplantation
© Copyright 1998-2013 IP Technology Exchange, Inc All rights reserved. Terms and Conditions | Contact us